Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients-Reference-Cited by-同舟云学术

Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients

Published:2015-06 Issue:6 Volume:26 Page:1238-1244
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Hecht M.,Zimmer L.,Loquai C.,Weishaupt C.,Gutzmer R.,Schuster B.,Gleisner S.,Schulze B.,Goldinger S.M.,Berking C.,Forschner A.,Clemens P.,Grabenbauer G.,Müller-Brenne T.,Bauch J.,Eich H.T.,Grabbe S.,Schadendorf D.,Schuler G.,Keikavoussi P.,Semrau S.,Fietkau R.,Distel L.V.,Heinzerling L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/26/6/1238/5246510/mdv139.pdf

Reference28 articles.

1. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

2. Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study;McArthur;Lancet Oncol,2014

3. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial;Hauschild;Lancet,2012

4. Melanoma brain metastasis: overview of current management and emerging targeted therapies;Fonkem;Expert Rev Neurother,2012

5. Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma;Anker;J Clin Oncol,2013

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and tolerability of radiotherapy in combination with systemic targeted therapies for treatment of hepatocellular carcinoma: a narrative review;Chinese Clinical Oncology;2024-06

2. Systemic Treatment of Melanoma;Rook's Textbook of Dermatology;2024-03-19

3. Combining radiation and systemic therapy;Palliative Radiation Oncology;2024

4. Management of melanoma central nervous system metastases;Oncology in Clinical Practice;2023-10-17

5. A Rare Case of BRAF-mutated Metastatic Pleomorphic Xanthoastrocytoma Patient who Developed Radiodermatitis After Receiving Anti-BRAF Treatment;Journal of Pediatric Hematology/Oncology;2023-09-13